List of adverse effects of axitinib

From WikiProjectMed
Jump to navigation Jump to search


This is a list of adverse effects of the anti-cancer drug axitinib, sorted by frequency of occurrence.[1][2][3][4][5][6]

Very common

Very common (>10% incidence) adverse effects include:

Common

Common (1–10% incidence) adverse effects include:

Uncommon

Uncommon (0.1–1% incidence) adverse effects include:

References

  1. "Inlyta (axitinib) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Archived from the original on 5 July 2018. Retrieved 25 January 2014.
  2. "INLYTA (axitinib) tablet, film coated [Pfizer Laboratories Div Pfizer Inc]". DailyMed. Pfizer Laboratories Div Pfizer Inc. September 2013. Archived from the original on 27 November 2019. Retrieved 25 January 2014.
  3. "Inlyta : EPAR - Product Information" (PDF). European Medicines Agency. Pfizer Ltd. 17 December 2013. Archived (PDF) from the original on 5 July 2018. Retrieved 25 January 2014.
  4. "Inlyta 1 mg 3mg, 5 mg & 7mg film-coated tablets - Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Pfizer Limited. 5 December 2013. Archived from the original on 22 February 2014. Retrieved 25 January 2014.
  5. "PRODUCT INFORMATION INLYTA (axitinib)" (PDF). TGA eBusiness Services. Pfizer Australia Pty Ltd. 5 July 2013. Archived from the original on 29 March 2019. Retrieved 25 January 2014.
  6. Rossi, S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust. ISBN 978-0-9805790-9-3.